Swiss law requires that new drug applications be made by a Swiss company. PFC serves as the local “agent” for foreign and national companies for contact to and submissions to Swissmedic, the Swiss regulatory authority and provides services to the requested degree.

European community: together with our partner company, Brinker Pharmaconsulting (www.brinkerpharma.de), we have capabilities in dossier submissions - both mutual recognition as well as centralistic procedures.